ArticleDrugs in context2025

Real-world analysis of IL-23 inhibitors in patients with moderate-to-severe psoriasis and early musculoskeletal symptoms.

Annunziata Dattola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.